Policy | July 2019

The American Society of Radiologic Technologists (ASRT) Board of Directors has announced that more research is required before it feels comfortable recommending the discontinuation of patient gonadal and fetal shielding during x-rays.

According to a new study published in JAMA Internal Medicine, providers should consider only discussing supplemental imaging with women with dense breasts if the patients are specifically at a higher risk for breast cancer.

DenseBreast-info, Inc. (DB-I) has shared its public comments on the FDA’s proposed changes to the Mammography Quality Standards Act of 1992 (MQSA). The FDA first announced its efforts to amend the MQSA back in March.

The American Medical Association (AMA) has endorsed a list of healthcare policy recommendations designed to emphasize AI’s ability to improve patient care, reduce costs and support physicians.

Financial conflicts of interest (FCOIs) do not appear to impact or influence the development of consensus breast cancer screening recommendations, according to a new study published in the Journal of the American College of Radiology.

A representative from the Medical Imaging & Technology Alliance (MITA) spoke at a public hearing organized by the Department of Health and Human Services, sharing insight into how patients can gain better access to key technologies.

The U.S. Pharmacopeia (USP) has published a new chapter on the minimum standards required to prepare, compound, dispense and repackage both sterile and non-sterile radiopharmaceuticals associated with state-licensed activities.

The FDA has published two new guidance documents designed to align the agency’s requirements for x-ray imaging devices with various international standards.